1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Breast Reconstruction Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Breast Reconstruction Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. New Product Launch and Regulatory Approvals
5.2. Novel Technology in Breast Reconstruction
6. Global Breast Reconstruction Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2027
6.3.1. Breast Implants
6.3.1.1. Silicone
6.3.1.2. Saline
6.3.2. Tissue Expanders
6.3.3. Acellular Dermal Matrices (ADM)
6.4. Market Attractiveness, by Product
7. Global Breast Reconstruction Market Analysis and Forecast, by End User
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End User, 2017–2027
7.3.1. Hospitals
7.3.2. Ambulatory Care Centers
7.4. Market Attractiveness, by End User
8. Global Breast Reconstruction Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Breast Reconstruction Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2027
9.2.1. Breast Implants
9.2.1.1. Silicone
9.2.1.2. Saline
9.2.2. Tissue Expanders
9.2.3. Acellular Dermal Matrices (ADM)
9.3. Market Value Forecast, by End User, 2017–2027
9.3.1. Hospitals
9.3.2. Ambulatory Care Centers
9.4. Market Value Forecast, by Country, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End User
9.5.3. By Country
10. Europe Breast Reconstruction Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product , 2017–2027
10.2.1. Breast Implants
10.2.1.1. Silicone
10.2.1.2. Saline
10.2.2. Tissue Expanders
10.2.3. Acellular Dermal Matrices (ADM)
10.3. Market Value Forecast, by End User, 2017–2027
10.3.1. Hospitals
10.3.2. Ambulatory Care Centers
10.4. Market Value Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End User
10.5.3. By Country/Sub-region
11. Asia Pacific Breast Reconstruction Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2027
11.2.1. Breast Implants
11.2.1.1. Silicone
11.2.1.2. Saline
11.2.2. Tissue Expanders
11.2.3. Acellular Dermal Matrices (ADM)
11.3. Market Value Forecast, by End User, 2017–2027
11.3.1. Hospitals
11.3.2. Ambulatory Care Centers
11.4. Market Value Forecast, by Country/Sub-region, 2017–2027
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End User
11.5.3. By Country/Sub-region
12. Latin America Breast Reconstruction Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2027
12.2.1. Breast Implants
12.2.1.1. Silicone
12.2.1.2. Saline
12.2.2. Tissue Expanders
12.2.3. Acellular Dermal Matrices (ADM)
12.3. Market Value Forecast, by End User, 2017–2027
12.3.1. Hospitals
12.3.2. Ambulatory Care Centers
12.4. Market Value Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End User
12.5.3. By Country/Sub-region
13. Middle East & Africa Breast Reconstruction Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2027
13.2.1. Breast Implants
13.2.1.1. Silicone
13.2.1.2. Saline
13.2.2. Tissue Expanders
13.2.3. Acellular Dermal Matrices (ADM)
13.3. Market Value Forecast, by End User, 2017–2027
13.3.1. Hospitals
13.3.2. Ambulatory Care Centers
13.4. Market Value Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End User
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Share Analysis, by Company (2018)
14.2. Company Profiles
14.2.1. Allergan
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Financial Overview
14.2.1.3. Product Portfolio
14.2.1.4. SWOT Analysis
14.2.1.5. Strategic Overview
14.2.2. Mentor Worldwide LLC (Johnson & Johnson)
14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.2.2. Financial Overview
14.2.2.3. Product Portfolio
14.2.2.4. SWOT Analysis
14.2.2.5. Strategic Overview
14.2.3. Sientra, Inc.
14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.3.2. Financial Overview
14.2.3.3. Product Portfolio
14.2.3.4. SWOT Analysis
14.2.3.5. Strategic Overview
14.2.4. Establishment Labs S.A.
14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.4.2. Financial Overview
14.2.4.3. Product Portfolio
14.2.4.4. SWOT Analysis
14.2.4.5. Strategic Overview
14.2.5. POLYTECH Health & Aesthetics GmbH
14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.5.2. Financial Overview
14.2.5.3. Product Portfolio
14.2.5.4. SWOT Analysis
14.2.5.5. Strategic Overview
14.2.6. RTI Surgical, Inc.
14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.6.2. Financial Overview
14.2.6.3. Product Portfolio
14.2.6.4. SWOT Analysis
14.2.6.5. Strategic Overview
14.2.7. Groupe Sebbin SAS
14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.7.2. Financial Overview
14.2.7.3. Product Portfolio
14.2.7.4. SWOT Analysis
14.2.7.5. Strategic Overview
14.2.8. Integra LifeSciences
14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.8.2. Financial Overview
14.2.8.3. Product Portfolio
14.2.8.4. SWOT Analysis
14.2.8.5. Strategic Overview
14.2.9. Wanhe
14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.9.2. Financial Overview
14.2.9.3. Product Portfolio
14.2.9.4. SWOT Analysis
14.2.9.5. Strategic Overview
14.2.10. GC Aesthetics
14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.10.2. Financial Overview
14.2.10.3. Product Portfolio
14.2.10.4. SWOT Analysis
14.2.10.5. Strategic Overview